Clinical Trial Update: A Study of Obinutuzumab (GA101; RO5072759) in Combination With Chemotherapy in Participants With Previously Untreated Chronic Lymphocytic Leukemia (CLL) (GALTON) [Phase 1]

View source ↗

Summary

This clinical trial update reports Phase 1 results for obinutuzumab in combination with chemotherapy in previously untreated chronic lymphocytic leukemia (GALTO…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Lymphocytic Leukemia

Drugs mentioned

• Gazyva (Obinutuzumab)

Snippet

Sponsor: Genentech, Inc. | Conditions: Lymphocytic Leukemia, Chronic | Phase 1 | Status: COMPLETED | Results posted: 2016-06-24